# Endoscopic Mucosal Resection and Cellular Matrix

> **NCT03240679** · NA · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 3 (actual)

## Conditions studied

- Barretts Esophagus With High Grade Dysplasia
- Barrett Adenocarcinoma

## Interventions

- **DEVICE:** Acell MatriStem® Surgical Matrix

## Key facts

- **NCT ID:** NCT03240679
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-03-22
- **Primary completion:** 2017-06-20
- **Final completion:** 2017-06-20
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Difficulty obtaining investigational product and study support.
- **Last updated:** 2023-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03240679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03240679, "Endoscopic Mucosal Resection and Cellular Matrix". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03240679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*